You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Homozygous Familial Hypercholesterolemia (HoFH)

Showing 1 - 25 of 1,416
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Homozygous Familial Hypercholesterolemia Trial in Australia, Canada, United States (ARO-ANG 3 Injection)

Recruiting
  • Homozygous Familial Hypercholesterolemia
  • ARO-ANG 3 Injection
  • Mount Sinai, New York
  • +7 more
Sep 26, 2022

Vytorin Reexamination Study (0653A-174)

Completed
Has Results
  • Primary Hypercholesterolemia and Homozygous Familial Hypercholesterolemia (HoFH)
    • (no location specified)
    Feb 7, 2022

    Homozygous Familial Hypercholesterolemia Trial in Netherlands, South Africa, United States (Demographics, diagnosis type,

    Recruiting
    • Homozygous Familial Hypercholesterolemia
    • Demographics, diagnosis type, genotype, lipid profile, treatment allocation, country of residence.
    • Philadelphia, Pennsylvania
    • +3 more
    Sep 28, 2022

    Heterozygous or Homozygous Familial Hypercholesterolemia Trial (Inclisiran)

    Not yet recruiting
    • Heterozygous or Homozygous Familial Hypercholesterolemia
    • (no location specified)
    Dec 27, 2022

    Identifying and Genotyping Homozygous Familial

    Completed
    • Homozygous Familial Hypercholesterolemia (HoFH)
      • Boca Raton, Florida
        Excel Medical Clinical Trials, LLC
      Jan 28, 2021

      Homozygous Familial Hypercholesterolemia Trial in Xi'an (NGGT006)

      Not yet recruiting
      • Homozygous Familial Hypercholesterolemia
      • NGGT006
      • Xi'an, Shaanxi, China
        First Affiliated Hospital of Xian Jiaotong University
      Nov 5, 2023

      Hyperlipemia Trial in Beijing (JS002)

      Active, not recruiting
      • Hyperlipemia
      • Beijing, Beijing, China
        Beijing Anzhen Hospital Capital Medical University
      Jan 24, 2022

      Homozygous Familial Hypercholesterolaemia (HoFH) Trial in Worldwide (Lomitapide)

      Recruiting
      • Homozygous Familial Hypercholesterolaemia (HoFH)
      • Heidelberg, Baden-Wurttemberg, Germany
      • +13 more
      Apr 4, 2022

      Study to Evaluate the Safety and Efficacy of RGX-501

      Active, not recruiting
      • Homozygous Familial Hypercholesterolemia (HoFH)
      • Single intravenous (IV) dose of human Low Density Lipoprotein Receptor (LDLR) Gene Therapy
      • Columbus, Ohio
      • +5 more
      Jun 7, 2021

      Homozygous Familial Hypercholesterolemia HoFH Trial in India (evolocumab)

      Completed
      Has Results
      • Homozygous Familial Hypercholesterolemia HoFH
      • New Delhi, Delhi, India
      • +11 more
      Nov 13, 2020

      Homozygous Familial Hypercholesterolemia Trial in Worldwide (lerodalcibep, evolocumab)

      Active, not recruiting
      • Homozygous Familial Hypercholesterolemia
      • Evanston, Illinois
      • +11 more
      Jul 13, 2022

      Homozygous Familial Hypercholesterolemia Trial (SHR-1918)

      Not yet recruiting
      • Homozygous Familial Hypercholesterolemia
      • (no location specified)
      Aug 22, 2023

      Homozygous Familial Hypercholesterolemia Trial in Worldwide (Alirocumab, Placebo)

      Completed
      Has Results
      • Homozygous Familial Hypercholesterolemia
      • Boca Raton, Florida
      • +27 more
      Jun 7, 2021

      Homozygous Familial Hypercholesterolemia Trial (Evinacumab)

      Not yet recruiting
      • Homozygous Familial Hypercholesterolemia
      • (no location specified)
      Nov 3, 2022

      Homozygous Familial Hypercholesterolemia Trial in Worldwide (Evinacumab)

      Active, not recruiting
      • Homozygous Familial Hypercholesterolemia
      • Wilmington, Delaware
      • +10 more
      Jan 30, 2023

      Homozygous Familial Hypercholesterolemia Trial in Los Angeles, Amsterdam, Parktown (ALN-PCSSC, Standard of Care)

      Completed
      Has Results
      • Homozygous Familial Hypercholesterolemia
      • Los Angeles, California
      • +2 more
      May 14, 2020

      Familial Hypercholesterolemia Trial in Worldwide (Evolocumab)

      Completed
      Has Results
      • Familial Hypercholesterolemia
      • Evolocumab
      • Bronx, New York
      • +45 more
      Dec 16, 2021

      Hypercholesterolemia, Familial Trial in Philadelphia, Amsterdam (Kinetics test)

      Completed
      • Hypercholesterolemia, Familial
      • Kinetics test
      • Philadelphia, Pennsylvania
      • +1 more
      May 14, 2021

      Homozygous Familial Hypercholesterolemia Trial in Beijing (IBI306)

      Active, not recruiting
      • Homozygous Familial Hypercholesterolemia
      • IBI306
      • Beijing, China
        Beijing Anzhen Hospital, Capital Medical University
      Sep 12, 2022

      Patients With High Cholesterol and Normal Volunteers

      Completed
      • Homozygous Familial Hypercholesterolemic
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 12, 2023

        The Rogosin Institute Homozygous Familial Hypercholesterolemia

        Recruiting
        • Homozygous Familial Hypercholesterolemia
          • New York, New York
            The Rogosin Institute, Weill Cornell Medical College
          Feb 28, 2022

          Homozygous Familial Hypercholesterolemia Trial in Worldwide (evinacumab)

          Active, not recruiting
          • Homozygous Familial Hypercholesterolemia
          • Los Angeles, California
          • +37 more
          Feb 17, 2022

          Homozygous Familial Hypercholesterolemia Trial in Canada, Netherlands, United States (REGN1500 250 mg SC/15 mg/kg IV/450 mg SC)

          Completed
          Has Results
          • Homozygous Familial Hypercholesterolemia
          • REGN1500 250 mg SC/15 mg/kg IV/450 mg SC
          • Los Angeles, California
          • +4 more
          Dec 6, 2019

          Biomarker for Homozygous Familial Hypercholesterolemia (BioHoFH)

          Active, not recruiting
          • Lipoprotein Lipase Deficiency
          • +2 more
            • Rostock, Germany
            • +3 more
            May 12, 2021

            Homozygous Familial Hypercholesterolemia Trial in Beijing (AK102, Statins, Ezetimibe)

            Unknown status
            • Homozygous Familial Hypercholesterolemia
            • Beijing, Beijing, China
            • +1 more
            Nov 17, 2019